Antigen-Specific Immune Responses and Clinical Outcome After Vaccination With Glioma-Associated Antigen Peptides and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Children With Newly Diagnosed Malignant Brainstem and Nonbrainstem Gliomas [Pediatric Oncology]
Conclusion
GAA peptide vaccination in children with gliomas is generally well tolerated and has preliminary evidence of immunologic and clinical responses. Careful monitoring and management of pseudoprogression is essential.
Source: Journal of Clinical Oncology - Category: Cancer & Oncology Authors: Pollack, Jakacki, Butterfield, Hamilton, Panigrahy, Potter, Connelly, Dibridge, Whiteside, Okada Tags: Brain Tumors, CNS Tumors Pediatric Oncology Source Type: research
More News: Allergy & Immunology | Brain | Brain Cancers | Brain Stem Giloma | Brain Tumor | Cancer & Oncology | Chemotherapy | Children | Dexamethasone | Glioma | MRI Scan | Neurology | Pediatrics | Study | Toxicology | Vaccines